Tranche 2 Draw Period definition
Tranche 2 Draw Period means the period beginning on achievement of Performance Milestone I and continuing through the earlier of (a) June 15, 2023 and (b) the occurrence of an Event of Default that continues.
Tranche 2 Draw Period is the period of time commencing on the date of a Tranche 2 Event and continuing through March 31, 2019.
Tranche 2 Draw Period the period commencing on the Tranche 2 Milestone Date and ending on the earliest of (a) June 30, 2027, (b) the date on which the Delayed Draw Term Loan Commitments are terminated pursuant to a Delayed Draw Termination Notice, and (c) the day on which the Tranche 2 Delayed Draw Term Loan Commitments have been reduced to zero as a result of the funding of Tranche 2 Delayed Draw Term Loans or the termination of the Commitments hereunder as a result of the acceleration of the Obligations.
Examples of Tranche 2 Draw Period in a sentence
In addition, subject to the terms and conditions hereof, upon ▇▇▇▇▇▇▇▇’s written request therefor made at any time during the Tranche 2 Draw Period, each Delayed Draw Term Loan Lender severally agrees to make Delayed Draw Term Loan(s) to the Borrower in an aggregate amount not to exceed the Tranche 2 Delayed Draw Term Loan Commitment of such Lender (each, a “Tranche 2 Delayed Draw Term Loan”), and once repaid in accordance with the provisions hereof may not be reborrowed.
More Definitions of Tranche 2 Draw Period
Tranche 2 Draw Period is the period of time commencing on the date on which Borrower achieves the Tranche 2 Availability Milestone and ending on the earlier to occur of (a) June 30, 2027, and (b) an Event of Default. TO: Silicon Valley Bank, a division of FIRST-CITIZENS BANK & TRUST COMPANY FROM: ALAMAR BIOSCIENCES, INC. Date: Under the terms and conditions of the Loan and Security Agreement between Borrower and Bank (as amended, modified, supplemented and/or restated from time to time, the “Agreement”), Borrower is in complete compliance for the period ending with all required covenants except as noted below. Attached are the required documents evidencing such compliance, setting forth calculations prepared in accordance with GAAP consistently applied from one period to the next except as explained in an accompanying letter or footnotes. Capitalized terms used but not otherwise defined herein shall have the meanings given them in the Agreement.
Tranche 2 Draw Period. “Tranche 2 Draw Period” is the period of time commencing on the date on which Borrower achieves the Tranche 2 Availability Milestone and ending on the earlier to occur of (a) June 30, 2027, and (b) an Event of Default. TO: Silicon Valley Bank, a division of FIRST-CITIZENS BANK & TRUST COMPANY FROM: ALAMAR BIOSCIENCES, INC. Date: Under the terms and conditions of the Loan and Security Agreement between Borrower and Bank (as amended, modified, supplemented and/or restated from time to time, the “Agreement”), Borrower is in complete compliance for the period ending with all required covenants except as noted below. Attached are the required documents evidencing such compliance, setting forth calculations prepared in accordance with GAAP consistently applied from one period to the next except as explained in an accompanying letter or footnotes. Capitalized terms used but not otherwise defined herein shall have the meanings given them in the Agreement.
Tranche 2 Draw Period means the period beginning on achievement of Performance Milestone I and continuing through the earlier of
Tranche 2 Draw Period means, on and after Tranche 2 Draw Conditions have been met, the period beginning on the earlier of (i) the full draw of the Tranche 1E Advances and (ii) the expiration of Tranche 1E Draw Period, and ending on June 30, 2024.
Tranche 2 Draw Period is the period commencing on the date of the occurrence of the Tranche 2 Draw Date and ending on the earlier of (i) December 31, 2016, and (ii) the occurrence of an Event of Default; provided, however, that the Tranche 2 Draw Period shall not commence if on the date of the occurrence of the Tranche 2 Draw Date Event an Event of Default has occurred and is continuing.
Tranche 2 Draw Period is set forth on Schedule I hereto.
Tranche 2 Draw Period means the period beginning on the date of ▇▇▇▇▇▇▇▇’s achievement of the NDA Milestone and continuing through the earlier of (a) ten (10) Business Days following Borrower’s achievement of the NDA Milestone and (b) September 15, 2023. “Tranche 2 Facility Charge” means $62,500 which is payable to Lender in accordance with Section 4.2(g), subject to funding of the Tranche 2 Advance. “Tranche 3 Advance” has the meaning set forth in Section 2.2(a)(iii). “Tranche 3 Draw Period” means the period beginning on the date of ▇▇▇▇▇▇▇▇’s achievement of the Approval Milestone and continuing through the earlier of (a) ten (10) Business Days following ▇▇▇▇▇▇▇▇’s achievement of the Approval Milestone and (b) February 15, 2024. “Tranche 3 Facility Charge” means $250,000 which is payable to Lender in accordance with Section 4.2(h), subject to funding of the Tranche 3 Advance. “Tranche 4 Advance” has the meaning set forth in Section 2.2(a)(iv). “Tranche 4 Facility Charge” means $125,000 which is payable to Lender in accordance with Section 4.2(i), subject to funding of the Tranche 4 Advance. “UCC” means the Uniform Commercial Code as the same is, from time to time, in effect in the State of California; provided, that in the event that, by reason of mandatory provisions of law, any or all of the attachment, perfection or priority of, or remedies with respect to, Agent’s Lien on any Collateral is governed by the Uniform Commercial Code as the same is, from time to time, in effect in a jurisdiction other than the State of California, then the term “UCC” shall mean the Uniform Commercial Code as in effect, from time to time, in such other jurisdiction solely for purposes of the provisions thereof relating to such attachment, perfection, priority or remedies and for purposes of definitions related to such provisions. “Unrestricted Cash” means Cash held by Borrower subject to an Account Control Agreement. “VALOR-CKD Milestone” means Borrower’s VALOR-CKD trial, ▇▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ identifier #NCT03710291, has demonstrated Positive Data where such Positive Data would be expected to support Borrower’s resubmission and subsequent FDA filing of the NDA for TRC101 (a/k/a veverimer) as the next immediate step in clinical development, subject to verification by Agent (including supporting documentation requested by Agent, to the extent such documentation is available to Borrower).